Pharma Equity Group A/S

kr 0.07As of Sun 8 Nov 2026, 12:00 UTC
CPH:PEGHealthcare
Country Denmark
PE (Fwd) •••
TSR 4Y CAGR (43.38%)
Div yield —
ROE (32.07%)
Biotechnology
Beta (5Y) 1.04
PE TTM —
TSR TTM (34.58%)
Mkt cap kr 85.93M
ROIC (13.10%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 0.0896
28.05%
(76.98%)
Hold 0|2|7|3|12
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
—
—
—
—
5.85%
6.77%
15.77%
6.96%
Revenuekr M
6.177
6.101
5.991
5.871
1.11%
1.56%
(1.65%)
(2.21%)
Peers (US$12.81M)
Cap (US$)
PE
25.02M
—
3.638M
18.36x
12.79M
—
Capital
TTM
5Y
10Y
Leveragex
0.625
0.733
0.537
EBIT/Intx
0.875
0.457
0.404
Own earn%
41.96
63.53
80.06
Sh yield%
28.10
22.71
24.25
Owners
Insiders/Inst%
13.41
28.16
Short interest%
1.69
SBC / revenue%
0.99
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
4–10
$1 testx
−0.2
Incr. ROIC%
17